EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma

Silvia Mara Baez Rodriguez, Amira Kamel, Gheorghe Vasile Ciubotaru, Gelu Onose iD, Ani-Simona Sevastre, Veronica Sfredel, Suzana Danoiu, Anica Dricu iD, Ligia Gabriela Tataranu iD

International Journal of Molecular Sciences · 05.07.2023 · 24 (13) · 11110

DOI: 10.3390/ijms241311110 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.07.2023. Verfasst von Silvia Mara Baez Rodriguez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgical Department, Clinical Emergency Hospital "Bagdasar-Arseni", Soseaua Berceni 12, 041915 Bucharest, Romania. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Glioma. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii, UEFISCDI, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite all of the progress in understanding its molecular biology and pathogenesis, glioblastoma (GBM) is one of the most aggressive types of cancers, and without an efficient treatment modality at the moment, it remains largely incurable. Nowadays, one of the most frequently studied molecules with important implications in the pathogenesis of the classical subtype of GBM is the epidermal growth factor receptor (EGFR). Although many clinical trials aiming to study EGFR targeted therapies have been performed, none of them have reported promising clinical results when used in glioma patients. The resistance of GBM to these therapies was proven to be both acquired and innate, and it seems to be influenced by a cumulus of factors such as ineffective blood–brain barrier penetration, mutations, heterogeneity and compensatory signaling pathways. Recently, it was shown that EGFR possesses kinase-independent (KID) pro-survival functions in cancer cells. It seems imperative to understand how the EGFR signaling pathways function and how they interconnect with other pathways. Furthermore, it is important to identify the mechanisms of drug resistance and to develop better tailored therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsGliomaHumansErbB ReceptorsSignal Transduction

Stichwörter der Autor:innen

EGFREGFR targeted therapyRTKglioblastomagrowth factorsignaling pathways

Substanzen

ErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Neurosurgical Department, Clinical Emergency Hospital "Bagdasar-Arseni", Soseaua Berceni 12, 041915 Bucharest, Romania.
  • Neuromuscular Rehabilitation Department, Clinical Emergency Hospital "Bagdasar-Arseni", Soseaua Berceni 12, 041915 Bucharest, Romania.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, Str. Petru Rares nr. 2-4, 710204 Craiova, Romania.
  • Department of Physiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Str. Petru Rares nr. 2-4, 710204 Craiova, Romania.
  • Department of Biochemistry, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Str. Petru Rares nr. 2-4, 710204 Craiova, Romania.
  • Department of Neurosurgery, Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila", 020022 Bucharest, Romania.

ORCID-Profile: Gelu Onose, Anica Dricu, Ligia Gabriela Tataranu

Förderung

  • Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii
  • UEFISCDI, Romania

Zitieren

APA

Rodriguez, S. M. B., Kamel, A., Ciubotaru, G. V., Onose, G., Sevastre, A. S., Sfredel, V., Danoiu, S., Dricu, A., & Tataranu, L. G. (2023). An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma. International Journal of Molecular Sciences, 24(13), 11110. https://doi.org/10.3390/ijms241311110

Vancouver

Rodriguez SMB, Kamel A, Ciubotaru GV, Onose G, Sevastre AS, Sfredel V, et al. An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma. International Journal of Molecular Sciences. 2023;24(13):11110. doi:10.3390/ijms241311110

BibTeX
@article{Rodriguez2023,
  author = {Rodriguez, Silvia Mara Baez and Kamel, Amira and Ciubotaru, Gheorghe Vasile and Onose, Gelu and Sevastre, Ani-Simona and Sfredel, Veronica and Danoiu, Suzana and Dricu, Anica and Tataranu, Ligia Gabriela},
  title = {An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {11110},
  doi = {10.3390/ijms241311110}
}
Kostenlos starten →